This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_NASOPHARYNX_EXALLC for full statistics.
Malignant neoplasm of nasopharynx
C3_NASOPHARYNX
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
99 |
4. Check minimum number of eventsNone |
99 |
5. Include endpointsNone |
99 |
6. Filter based on genotype QC (FinnGen only) |
99 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of nasopharynx
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of nasopharynx, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of head and neck
- Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 99 | 39 | 60 |
| Unadjusted period prevalence (%) | 0.02 | 0.01 | 0.03 |
| Median age at first event (years) | 62.18 | 57.35 | 65.33 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 96
- Matched controls
- 961
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
UDH02
NOMESCO Finland
Rhinopharyngoscopy
57.9
44.5
52
19
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
183.0
42.9
42
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
214.9
40.2
39
*
8070/3-C11.9
ICD-O-3
Squamous cell carcinoma, NOS, of nasopharynx, NOS
+∞
35.7
32
*
C11.9
ICD-10 Finland
Malignant neoplasm: Nasopharynx, unspecified
+∞
32.1
29
*
130
Kela drug reimbursment
Malignant tumour
19.2
31.8
54
60
A03FA01
ATC
metoclopramide; systemic, rectal
11.4
25.5
61
127
EMA30
NOMESCO Finland
Biopsy of rhinopharynx
+∞
23.9
22
*
C11.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of nasopharynx
+∞
22.8
21
*
WF002
NOMESCO Finland
Radical radiotherapy
17.5
21.0
34
29
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
8.2
20.3
63
180
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
22.5
19.9
29
18
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
62.3
17.8
20
*
C11.1
ICD-10 Finland
Malignant neoplasm: Posterior wall of nasopharynx
+∞
17.2
16
*
D10.6
ICD-10 Finland
Benign neoplasm: Nasopharynx
+∞
17.2
16
*
C11.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of nasopharynx
+∞
17.2
16
*
C11.0
ICD-10 Finland
Malignant neoplasm: Superior wall of nasopharynx
+∞
17.2
16
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
35.5
15.9
20
7
N02AA05
ATC
oxycodone; systemic
7.4
15.6
43
94
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
19.7
15.4
23
15
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
43.7
15.1
18
5
UDQ12
NOMESCO Finland
Flexible laryngoscopy
11.9
14.8
28
32
EP1AE
NOMESCO Finland
Neck ultrasound examination
17.4
14.1
22
16
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
87.6
14.0
15
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
162.0
13.8
14
*
EBA10
NOMESCO Finland
Surgical removal of tooth
9.9
13.5
28
38
A04AA01
ATC
ondansetron; systemic, rectal
11.2
13.0
25
29
H65.2
ICD-10 Finland
Chronic serous otitis media
37.9
13.0
16
5
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
148.6
12.8
13
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
6.3
11.1
32
70
A04AA02
ATC
granisetron; systemic, transdermal
8.8
10.6
23
33
8010/3-C11.9
ICD-O-3
Carcinoma, NOS, of nasopharynx, NOS
+∞
10.6
10
*
A07AA02
ATC
nystatin; oral
9.8
10.0
20
25
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
7.1
10.0
25
45
H02AB02
ATC
dexamethasone; systemic
5.8
9.8
30
70
XX3DW
NOMESCO Finland
Time consuming IT work
6.2
9.8
28
60
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
33.9
9.7
12
*
DHA10
NOMESCO Finland
Biopsy of cavity of nose
110.5
9.6
10
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
110.5
9.6
10
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
10.8
9.5
18
20
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
9.5
9
*
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
+∞
9.5
9
*
WX199
NOMESCO Finland
Other local analgesia
21.2
9.2
13
7
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.8
8.7
52
229
UDM02
NOMESCO Finland
Sinoscopy
22.5
8.7
12
6
H65.3
ICD-10 Finland
Chronic mucoid otitis media
22.5
8.7
12
6
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
9.6
8.5
17
21
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
8.4
8
*
9680/3-C11.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of nasopharynx, NOS
+∞
8.4
8
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
19.3
8.3
12
7
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
36.8
8.3
10
*
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
36.8
8.3
10
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
9.9
8.2
16
19
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
7.7
7.9
18
28
R13
ICD-10 Finland
Dysphagia
7.7
7.9
18
28
ENA10
NOMESCO Finland
Biopsy of pharynx
86.5
7.5
8
*
8070/3-C11.2
ICD-O-3
Squamous cell carcinoma, NOS, of lateral wall of nasopharynx
+∞
7.4
7
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
13.5
7.3
12
10
J01CE02
ATC
phenoxymethylpenicillin; oral
3.6
6.9
77
506
A01AB09
ATC
miconazole; local oral
6.1
6.7
18
35
H66.0
ICD-10 Finland
Acute suppurative otitis media
8.4
6.7
14
19
WF003
NOMESCO Finland
Adjuvant radiotherapy
9.2
6.6
13
16
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
15.7
6.6
10
7
SAA03
NOMESCO Finland
Extended examination of mouth
3.2
6.5
45
209
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
74.6
6.5
7
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
19.6
6.4
9
5
8070/3-C11.1
ICD-O-3
Squamous cell carcinoma, NOS, of posterior wall of nasopharynx
+∞
6.3
6
*
8072/3-C11.9
ICD-O-3
Squamous cell carcinoma, large cell, nonkeratinizing, NOS, of nasopharynx, NOS
+∞
6.3
6
*
SXC05
NOMESCO Finland
Other oral or dental procedure
9.6
6.3
12
14
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
16.3
6.0
9
6
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
34
71
6.77
16.93
1.6
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
19
5
46.36
16.05
1.3
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
13
10
14.81
13.63
1.2
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
13
18
8.16
9.07
1.2
1.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
63
339
3.36
7.84
7.3
5.5
%
0.7
0.7
0.01
57
317
(3006504) Eosinophils/100 leukocytes in Blood
63
347
3.24
7.39
7.3
5.6
%
2.8
2.7
0.13
57
325
(3019069) Monocytes/100 leukocytes in Blood
63
350
3.20
7.23
7.6
6.0
%
9.2
8.7
0.53
57
330
(3007853) Bacteria identified in Skin by Aerobe culture
28
96
3.67
7.14
2.1
1.7
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
63
358
3.09
6.80
7.6
5.7
%
26.2
27.4
0.28
58
334
(3018010) Neutrophils/100 leukocytes in Blood
62
354
3.01
6.56
7.2
5.5
%
58.4
57.1
0.29
57
335
(42870588) Differential panel, method unspecified - Blood
50
255
2.94
6.49
7.2
5.7
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
60
344
2.89
6.17
6.0
4.7
g/l
34.1
35.8
1.20
53
323
(3026389) Candida sp identified in Specimen by Organism specific culture
9
6
16.30
6.02
1.3
1.7
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
63
377
2.85
5.87
6.8
5.4
e9/l
0.6
0.6
0.16
52
326
(3006315) Basophils [#/volume] in Blood
63
377
2.85
5.87
7.0
5.4
e9/l
0.0
0.0
0.43
52
327
(3013650) Neutrophils [#/volume] in Blood by Automated count
71
454
2.99
5.81
17.0
10.2
e9/l
4.0
4.0
0.06
63
393
(3019198) Lymphocytes [#/volume] in Blood
63
383
2.77
5.60
7.1
5.4
e9/l
1.4
1.9
1.64
55
340
(3013115) Eosinophils [#/volume] in Blood
63
393
2.66
5.16
7.3
5.6
e9/l
0.2
0.2
0.70
54
344
(40768804) Tissue Pathology biopsy report
54
318
2.54
4.91
3.1
1.9
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
61
383
2.54
4.81
9.8
7.0
mmol/l
1.2
1.2
0.50
53
323
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
57
348
2.50
4.75
8.4
5.4
mmol/l
1.2
1.2
0.66
52
316
(3021879) Hepatitis B virus core Ab [Presence] in Serum
15
47
3.58
4.26
1.3
1.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
41
228
2.36
4.06
4.0
4.4
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
23
97
2.79
4.02
6.5
4.1
u/l
217.8
261.9
0.85
23
90
(3042936) Bacteria identified in Isolate by Culture
26
117
2.66
4.02
1.7
2.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
11
29
4.14
3.92
1.8
2.7
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
44
264
2.20
3.54
5.0
3.6
mmol/l
2.3
2.3
0.03
38
236
(46235355) HIV 1 and 2 tests - Meaningful Use set
21
94
2.57
3.24
1.5
1.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
51
334
2.09
3.20
6.8
7.3
inr
1.2
1.2
—
10
96
(3044640) Blood type and Crossmatch panel - Blood
40
240
2.12
3.15
2.5
2.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
19
82
2.63
3.15
1.5
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
18
76
2.67
3.11
1.2
1.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
21
96
2.51
3.10
1.8
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
7
12
6.18
3.07
1.9
1.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
52
363
1.91
2.55
3.9
4.0
—
—
—
0
0
(3019225) pH of Specimen
17
78
2.42
2.48
3.4
4.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
12
5.24
2.44
2.2
2.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
8
23
3.69
2.32
1.8
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
31
187
1.96
2.31
13.1
6.8
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7
18
4.10
2.29
1.3
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
35
224
1.87
2.17
5.5
3.8
ph
7.4
7.4
—
6
45
(3036481) Cortisol [Moles/volume] in Serum or Plasma
16
78
2.25
2.04
2.1
1.8
nmol/l
386.7
376.0
0.09
16
70
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
63
752
0.55
2.00
5.9
6.1
mmol/mol
39.9
40.4
0.21
54
710
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
21
116
2.03
1.98
1.9
2.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
17
294
0.49
1.92
2.7
3.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
6
17
3.69
1.87
1.3
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
17
3.69
1.87
1.3
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
28
175
1.84
1.84
2.4
2.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
64
755
0.57
1.82
4.3
4.3
mmol/l
1.4
1.3
0.26
56
697
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
13
61
2.30
1.81
1.8
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
18
3.48
1.77
2.3
2.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
5
13
3.99
1.73
1.4
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
21
122
1.92
1.72
2.8
3.0
e6/l
3.2
1.6
0.55
11
73
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
69
794
0.57
1.70
5.4
5.4
mmol/l
2.9
2.7
0.71
60
734
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
19
3.29
1.69
2.2
1.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
29
188
1.77
1.69
1.5
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
11
50
2.35
1.64
1.5
2.0
—
—
—
0
0
(3002256) Pathology report gross observation
16
86
2.03
1.62
1.8
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
16
86
2.03
1.62
1.4
1.9
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
20
3.12
1.60
1.3
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
67
772
0.59
1.55
5.0
4.8
mmol/l
1.4
1.4
0.13
60
717
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
15
3.45
1.54
1.2
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
32
219
1.68
1.53
3.8
2.7
umol/l
332.7
7222.5
1.06
26
178
(3028026) IgM [Mass/volume] in Serum or Plasma
9
38
2.50
1.50
2.0
1.7
g/l
0.6
2.8
—
9
32
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
22
2.83
1.46
1.0
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
68
775
0.61
1.40
4.8
4.9
mmol/l
4.8
4.6
0.61
61
726
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
18
2.87
1.30
1.4
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
15
87
1.85
1.23
1.4
2.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
18
111
1.76
1.22
1.8
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
6
26
2.39
1.20
2.8
1.9
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
5
20
2.58
1.16
2.4
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
7
30
2.43
1.15
2.7
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
7
33
2.20
1.08
1.0
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
67
577
1.50
1.06
5.7
3.8
pmol/l
14.8
14.8
0.06
62
519
(3021440) Promyelocytes/100 leukocytes in Blood
11
61
1.90
1.03
7.2
3.0
%
0.0
0.2
—
6
22
(4034850)
0
28
0.00
0.99
0.0
17.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
12
70
1.81
0.97
6.8
2.9
%
1.3
1.0
—
6
25
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
19
128
1.60
0.95
2.5
2.7
e6/l
0.3
1.1
—
8
77
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
69
765
0.68
0.94
4.7
5.0
mmol/l
6.1
6.1
0.01
61
707
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
29
2.14
0.91
1.3
1.2
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
5
23
2.23
0.77
1.4
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
23
2.23
0.77
1.6
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
24
2.14
0.75
8.0
4.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
24
2.14
0.75
1.6
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
7
39
1.85
0.74
1.0
1.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
60
525
1.36
0.74
4.8
4.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
7
43
1.67
0.68
28.9
6.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
5
30
1.70
0.62
2.2
1.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
28
223
1.36
0.62
3.5
2.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
20
0.00
0.61
0.0
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
21
160
1.40
0.60
4.0
3.5
ng/l
22.6
125.2
1.98
16
131
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
39
328
1.31
0.60
1.6
1.9
pmol/l
87.4
92.3
0.27
14
167
(3012544) pH of Venous blood
11
73
1.57
0.59
2.6
4.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
6
37
1.66
0.56
4.2
3.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
9
134
0.64
0.56
2.8
2.3
umol/l
9.7
14.0
—
9
114
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
14
100
1.47
0.55
5.4
4.9
%
28.4
32.0
—
8
64
(3000330) Specific gravity of Urine by Test strip
6
38
1.62
0.55
4.3
3.9
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
76
709
1.31
0.48
6.3
4.6
mu/l
2.0
2.0
0.18
71
641
(40768797) Stomach Pathology biopsy report
16
122
1.37
0.46
1.2
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
40
349
1.25
0.44
10.9
9.8
e9/l
0.0
0.0
0.50
28
284
(3044889) 12 lead EKG panel
52
572
0.81
0.43
3.8
4.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
18
224
0.76
0.43
4.9
3.4
estimate
0.0
0.0
—
5
77
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
26
308
0.79
0.42
4.3
3.5
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
0
15
0.00
0.41
0.0
2.8
—
58.2
—
0
9
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
18
223
0.76
0.41
4.6
3.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
29
246
1.25
0.40
3.9
3.2
e6/l
29.7
305.0
0.56
23
195
(3021788) Differential panel - Synovial fluid
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
8
113
0.68
0.40
2.6
2.4
%
17.4
23.9
—
8
91
(3021447) Carbon dioxide [Partial pressure] in Venous blood
9
68
1.36
0.39
2.1
4.3
kpa
5.6
5.9
—
9
62
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
36
1.41
0.39
1.6
1.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
26
219
1.25
0.38
3.8
3.0
e6/l
0.2
0.3
0.27
19
170
(21494755) Public health laboratory ask at order entry panel
5
78
0.62
0.37
1.2
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
25
211
1.25
0.36
3.5
2.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
19
229
0.79
0.35
2.5
2.9
ug/l
0.7
0.8
0.54
13
141
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
34
384
0.83
0.35
5.1
5.2
ug/l
2.4
2.1
0.18
28
339
(3009508) Creatinine [Moles/volume] in Urine
21
249
0.80
0.34
3.0
3.0
mmol/l
7.4
8.0
0.23
14
214
(3007164) IgA [Mass/volume] in Serum or Plasma
18
147
1.27
0.34
2.7
1.3
g/l
2.4
2.4
0.02
13
81
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
34
301
1.20
0.31
1.8
2.1
nmol/l
71.7
75.6
0.36
29
262
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
7
56
1.27
0.30
1.9
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
7
56
1.27
0.30
1.6
2.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
21
178
1.23
0.29
2.2
1.8
mg/l
0.8
1.2
0.55
14
149
(3004789) Transferrin [Mass/volume] in Serum or Plasma
9
118
0.74
0.29
2.7
2.3
g/l
2.2
2.3
—
9
104
(3013512) EKG study
28
245
1.20
0.29
6.2
4.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
8
64
1.27
0.28
6.3
4.3
mmol/l
1.2
1.2
—
8
57
(3009261) Glucose [Presence] in Urine by Test strip
36
397
0.85
0.27
4.1
3.3
estimate
0.0
0.0
—
5
77
(3012516) Albumin [Mass/volume] in Urine
21
243
0.83
0.27
2.6
3.0
mg/l
8.4
294.7
0.62
13
167
(40768443) Skin Pathology biopsy report
5
40
1.26
0.23
1.4
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
2.2
—
0
10
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
10
0.00
0.21
0.0
3.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
0
12
0.00
0.21
0.0
1.4
—
1.5
—
0
12
(3022806) Fractional oxyhemoglobin in Capillary blood
0
13
0.00
0.21
0.0
1.3
—
91.6
—
0
13
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
32
291
1.15
0.21
3.5
3.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
20
176
1.17
0.19
6.3
3.9
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
11
131
0.82
0.18
1.2
1.2
iu/ml
10.3
21.1
—
6
43
(40761535) Cells panel - Urine sediment
5
65
0.76
0.17
1.6
3.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
36
387
0.89
0.17
5.7
4.5
estimate
0.0
0.0
—
5
83
(3019060) Gas panel - Arterial blood
5
69
0.71
0.17
14.6
3.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
13
111
1.20
0.17
6.5
8.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
28
305
0.89
0.16
4.3
4.5
%
24.5
21.0
0.51
12
141
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
7
85
0.81
0.15
6.1
3.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
30
279
1.11
0.13
5.8
3.6
e6/l
40.7
52.8
0.17
23
209
(40761511) CBC panel - Blood by Automated count
82
803
1.12
0.11
21.8
15.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
19
174
1.11
0.10
2.8
3.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
43
1.17
0.10
2.8
2.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
5
44
1.14
0.10
2.6
2.8
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
24
257
0.91
0.10
3.6
3.8
mg/mmol
1.0
6.7
2.29
14
167
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
5
47
1.07
0.09
24.8
4.4
mmol/l
26.0
24.7
—
5
47
(3000991) Gas panel - Venous blood
7
64
1.10
0.08
21.1
7.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
74
755
0.92
0.08
21.8
13.8
ml/min/173m2
77.9
78.2
0.04
63
620
(3000492) Spirometry study
6
70
0.85
0.08
1.3
1.6
—
—
—
0
0
(3015736) pH of Urine
31
296
1.07
0.07
3.0
3.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
62
632
0.95
0.05
28.5
18.2
%
13.7
13.8
0.21
57
616
(3009542) Hematocrit [Volume Fraction] of Blood
69
679
1.05
0.04
24.7
15.9
%
38.9
39.8
0.40
46
475
(3022145) Colonoscopy Study observation
11
107
1.03
0.00
1.1
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
41
405
1.02
0.00
3.0
2.8
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
84
836
1.03
0.00
27.5
17.8
umol/l
79.2
81.3
0.30
84
836
(3019309) Folate [Moles/volume] in Red Blood Cells
16
161
0.99
0.00
1.6
1.6
nmol/l
1098.6
1307.6
—
10
126
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
5.1
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
6.3
—
122.0
—
0
7
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
5.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
6
0.00
0.00
0.0
6.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
7
71
0.98
0.00
3.0
2.8
u/l
27.4
29.5
—
7
57
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
58.0
—
0
6
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
9
0.00
0.00
0.0
2.2
—
32.0
—
0
9
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
6
65
0.92
0.00
3.0
3.4
—
62.7
—
0
28
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
1.1
—
0
8
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
5
59
0.84
0.00
2.0
3.0
kpa
6.6
4.0
—
5
53
(3023410) Appearance of Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
6
0.00
0.00
0.0
1.0
—
9.2
—
0
6
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
5
0.00
-0.00
0.0
1.2
—
1.2
—
0
5
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
5
0.00
-0.00
0.0
2.8
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
-0.00
0.0
4.0
—
69.5
—
0
5
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_NASOPHARYNX – Malignant neoplasm of nasopharynx
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).